Validation & Proof Points
Clinical validation, institutional partnerships, and documented outcomes demonstrating Cliexa's market credibility.
Key Outcome Metrics
30%
Colorado Arthritis Center pilot
$30.8K
Single specialty practice ROI
64%
YoY revenue growth 2023-2024
$2.9M
2024 annual revenue
Clinical Validation Partners
Mayo Clinic Platform
cliexaAI Opioid Use Disorder (OUD) risk prediction solution qualified on Mayo Clinic Platform (January 2026). XGBoost-based predictive algorithm combined with cliexa's rules engine identifies and stratifies patients at risk of OUD.
First company selected for Mayo Clinic Platform_Accelerate program
American College of Cardiology
Co-developed cliexa-PULSE, a remote monitoring platform for cardiovascular care (atrial fibrillation, hypertension, heart failure). ACC Innovation Program participant since 2021. ACC is both a development partner and equity investor.
Channel to thousands of ACC member cardiology clinics
Colorado Arthritis Center
Piloted cliexa-RA on cliexaTrac for real-time tracking of patient symptoms and disease activity. Patients complete standardized assessments via app before visits, with auto-scored results in Greenway Health EMR.
30% reduction in patient visit time, $30.8K annual savings
University of Colorado College of Nursing
Collaborated to develop Info Viz for Health, a visual communication and education tool for HIV patients. Addressed low health literacy with intuitive care plan delivery via cliexa platform.
Improved CD4 counts and lower viral loads for tool users
Strategic Channel Partners
BDR Solutions
Strategic partnership to support federal health agencies. BDR works with U.S. Defense Health Agency (DHA), Veterans Affairs, and Military Health System. Recently awarded DHA's 'Digital Front Door' initiative.
Spring Parker
Alliance to jointly deliver performance improvement services. Spring Parker's consulting team identifies workflow and revenue challenges; Cliexa's technology is brought in as enabling solution.
Diginova Health
Partnership for Middle East market entry. Deploying cliexa's AI platform across hospitals in UAE to optimize operations, revenue cycle, and patient outcomes.
Clinical Validation
- Clinical Rules Engine validated since 2016
- Mayo Clinic Platform OUD solution qualification
- NIH Small Business Grant recipient
- Colorado Advanced Industries grant
Trusted Institutions
- Columbia University Medical Center
- Kartini Clinic (pediatric eating disorders)
- Multiple specialty practices nationwide
- Government health systems via BDR
Technical Credibility
- Azure Marketplace listing (cliexaARCH)
- Athenahealth Marketplace integration
- FHIR/SMART on FHIR compliance
- EMR-agnostic containerized architecture
Stakeholder Perspectives
"The cliexa platform represents a revolutionary approach to cardiovascular remote monitoring, enabling cardiologists to track symptoms, medications, and daily activity with seamless EMR integration."
American College of Cardiology Innovation Program
On cliexa-PULSE launch
"This collaboration addresses health literacy challenges among HIV-positive patients by conveying care plans in intuitive ways, resulting in improved clinical outcomes."
University of Colorado Nursing Research Team
On Info Viz for Health project
Market Validation
Total Addressable Market
$100B+
RCM ($65B) + CDSS ($1.2B) + RPM ($14B) combined U.S. market
Serviceable Market
Low $Bs
U.S. ambulatory care AI software for physician practices
Funding Raised
$6M
Including $2.74M in Feb 2025 from 18 investors